SEC Form 4 · accession 0000914190-17-000254
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott R. Ward
Officer — CEO and President · Director
Period of report
Aug 17, 2017
Accepted (ET)
Aug 21, 2017 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 17, 2017 | S | 5,529 | $30.4094 | D | 282,536 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F3 | — | holding | — | — | — | — | — | Common Stock | 34,297 | 34,297 | D |
Explanation of responses
- F1In connection with the vesting and delivery of restricted stock, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $30.52 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the Reporting Person's board membership.
- F4Represents the aggregate number of restricted stock units (all previously reported) held by reporting person that are payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.